AbSci (ABSI) Stock Forecast & Price Target

Compare

986 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ABSI Analyst Ratings

Strong Buy

7 Buy

0 Hold

0 Sell

Based on 7 analysts giving stock ratings to

AbSci

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ABSI Stock 12 Month Forecast

Average Price Target

$9.07

▲(210.62% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for AbSci in the last 3 months. The average price target is $9.07 with a high forecast of $13.00 and a low forecast of $6.40. The average price target represents a 210.62% change from the last price of $2.92.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","14":"$14","4.25":"$4.25","7.5":"$7.5","10.75":"$10.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$13.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.07,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$9.07</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$6.40</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,4.25,7.5,10.75,14],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.9,3.6769230769230767,4.453846153846154,5.230769230769231,6.007692307692308,6.7846153846153845,7.561538461538461,8.338461538461539,9.115384615384615,9.892307692307693,10.669230769230769,11.446153846153846,12.223076923076924,{"y":13,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.9,3.3746153846153844,3.8492307692307692,4.323846153846153,4.798461538461538,5.273076923076923,5.747692307692308,6.222307692307693,6.696923076923077,7.171538461538461,7.646153846153846,8.12076923076923,8.595384615384615,{"y":9.07,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.9,3.169230769230769,3.4384615384615387,3.707692307692308,3.976923076923077,4.246153846153846,4.515384615384615,4.784615384615385,5.053846153846154,5.323076923076924,5.592307692307692,5.861538461538462,6.130769230769231,{"y":6.4,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.01,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.04,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.4,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.62,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.92,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.15,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.62,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.85,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.4,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.03,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.73,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.59,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.9,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$13.00

Average Price Target$9.07

Lowest Price Target$6.40

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

Hold

2.74%

Upside

Reiterated

08/07/25

AbSci's overall stock score is primarily impacted by its weak financial performance, characterized by ongoing losses and cash flow challenges. However, the company's strategic initiatives, such as AI-driven drug discovery and potential partnerships, along with positive corporate events, provide some optimism for future growth. Technical indicators and valuation metrics remain mixed, reflecting the company's current transitional phase.

Sean LaamanMorgan Stanley

Morgan Stanley

$7→$6.4

Buy

119.18%

Upside

Reiterated

07/28/25

AbSci's Strategic Growth and Innovation: Analyst Recommends Buy with $6.40 Price Target

Debanjana ChatterjeeJonesTrading

JonesTrading

Buy

208.22%

Upside

Reiterated

05/14/25

Buy Rating for Absci: Strategic Advancements and Promising Clinical Trials Highlight Growth Potential

Swayampakula RamakanthH.C. Wainwright

H.C. Wainwright

Buy

139.73%

Upside

Reiterated

05/14/25

Promising Developments and Strategic Initiatives Drive Buy Rating for Absci

George FarmerScotiabank

Scotiabank

$13

Buy

345.21%

Upside

Reiterated

05/14/25

Scotiabank Keeps Their Buy Rating on AbSci (ABSI)

Gil BlumNeedham

Needham

Buy

208.22%

Upside

Reiterated

05/14/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Unknown AnalystGuggenheim

Not Ranked

Guggenheim

$10

Buy

242.47%

Upside

Reiterated

05/14/25

We remain Buy rated with a $10 price target.

Brendan SmithTD Cowen

TD Cowen

―

Buy

―

Reiterated

05/13/25

AbSci's Promising Clinical Advancements and Strategic Positioning Justify Buy Rating

Scott SchoenhausKeyBanc

KeyBanc

$5→$9

Buy

208.22%

Upside

Reiterated

04/16/25

KeyBanc Reaffirms Their Buy Rating on AbSci (ABSI)

Srikripa DevarakondaTruist Financial

Truist Financial

―

Buy

―

Assigned

01/21/25

AbSci (ABSI) Gets a Buy from Truist Financial

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

Hold

2.74%

Upside

Reiterated

08/07/25

Sean LaamanMorgan Stanley

Morgan Stanley

$7→$6.4

Buy

119.18%

Upside

Reiterated

07/28/25

AbSci's Strategic Growth and Innovation: Analyst Recommends Buy with $6.40 Price Target

Debanjana ChatterjeeJonesTrading

JonesTrading

Buy

208.22%

Upside

Reiterated

05/14/25

Buy Rating for Absci: Strategic Advancements and Promising Clinical Trials Highlight Growth Potential

Swayampakula RamakanthH.C. Wainwright

H.C. Wainwright

Buy

139.73%

Upside

Reiterated

05/14/25

Promising Developments and Strategic Initiatives Drive Buy Rating for Absci

George FarmerScotiabank

Scotiabank

$13

Buy

345.21%

Upside

Reiterated

05/14/25

Scotiabank Keeps Their Buy Rating on AbSci (ABSI)

Gil BlumNeedham

Needham

Buy

208.22%

Upside

Reiterated

05/14/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Unknown AnalystGuggenheim

Not Ranked

Guggenheim

$10

Buy

242.47%

Upside

Reiterated

05/14/25

We remain Buy rated with a $10 price target.

Brendan SmithTD Cowen

TD Cowen

―

Buy

―

Reiterated

05/13/25

AbSci's Promising Clinical Advancements and Strategic Positioning Justify Buy Rating

Scott SchoenhausKeyBanc

KeyBanc

$5→$9

Buy

208.22%

Upside

Reiterated

04/16/25

KeyBanc Reaffirms Their Buy Rating on AbSci (ABSI)

Srikripa DevarakondaTruist Financial

Truist Financial

―

Buy

―

Assigned

01/21/25

AbSci (ABSI) Gets a Buy from Truist Financial

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering AbSci

1 Month

xxx

Success Rate

4/6 ratings generated profit

Average Return

+19.30%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +19.30% per trade.

3 Months

xxx

Success Rate

3/6 ratings generated profit

Average Return

+26.43%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +26.43% per trade.

1 Year

Swayampakula RamakanthH.C. Wainwright

Success Rate

4/13 ratings generated profit

Average Return

+42.82%

reiterated a buy rating 3 months ago

Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of +42.82% per trade.

2 Years

xxx

Success Rate

4/13 ratings generated profit

Average Return

+19.14%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 30.77% of your transactions generating a profit, with an average return of +19.14% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ABSI Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ABSI has received 2 Buy Ratings, 8 Hold Ratings, and 1 Sell Ratings. ABSI average Analyst price target in the past 3 months is 9.07.

Each month's total comprises the sum of three months' worth of ratings.

ABSI Financial Forecast

ABSI Earnings Forecast

Next quarter’s earnings estimate for ABSI is -$0.21 with a range of -$0.24 to -$0.17. The previous quarter’s EPS was -$0.21. ABSI beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.46% of the time in the same period. In the last calendar year ABSI has Outperformed its overall industry.

ABSI Sales Forecast

Next quarter’s sales forecast for ABSI is $1.35M with a range of $0.00 to $2.29M. The previous quarter’s sales results were $1.18M. ABSI beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 48.05% of the time in the same period. In the last calendar year ABSI has Preformed in-line its overall industry.

ABSI Stock Forecast FAQ

What is ABSI’s average 12-month price target, according to analysts?

Based on analyst ratings, AbSci’s 12-month average price target is 9.07.

What is ABSI’s upside potential, based on the analysts’ average price target?

AbSci has 210.62% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ABSI a Buy, Sell or Hold?

AbSci has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.

What is AbSci’s price target?

The average price target for AbSci is 9.07. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $13.00 ,the lowest forecast is $6.40. The average price target represents 210.62% Increase from the current price of $2.92.

What do analysts say about AbSci?

AbSci’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of ABSI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

AbSci (ABSI) Stock Forecast & Price Target

ABSI Analyst Ratings

ABSI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering AbSci

ABSI Analyst Recommendation Trends

ABSI Financial Forecast

ABSI Earnings Forecast

ABSI Sales Forecast

ABSI Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts